102
Participants
Start Date
November 19, 2013
Primary Completion Date
September 4, 2015
Study Completion Date
July 19, 2017
Trastuzumab
Trastuzumab 8 mg/kg (loading dose) and 6 mg/kg (maintenance dose) IV infusion q3w; Trastuzumab 600 mg q3w SC injection will be administered as per the schedule specified in the arm.
CHU St Pierre (St Pierre), Brussels
AZ Turnhout Sint Elisabeth, Turnhout
Imeldaziekenhuis, Bonheiden
Clinique Saint-Joseph, Liège
CHR de Namur, Namur
CHU Ambroise Paré, Mons
CH Jolimont - Lobbes (Jolimont), Haine-Saint-Paul
AZ Sint Jan, Bruges
AZ Damiaan, Ostend
AZ Maria Middelares, Ghent
AZ Sint Lucas (Sint Lucas), Ghent
UZ Gent, Ghent
Onze Lieve Vrouwziekenhuis Aalst, Aalst
Western Galilee Hospital; Oncology-Nahariya, Nahariya
Rambam Medical Center; Oncology, Haifa
Meir Medical Center; Oncology, Kfar Saba
Rabin MC; Davidof Center - Oncology Institute, Petah Tikva
Chaim Sheba medical center, Oncology division, Ramat Gan
Assaf Harofeh; Oncology, Ẕerifin
Sourasky / Ichilov Hospital; Dept. of Oncology, Tel Aviv
Kaplan Medical Center; Oncology Inst., Rehovot
Soroka Medical Center; Oncology Dept, Beersheba
Hadassah Ein Karem Hospital; Oncology Dept, Jerusalem
Hoffmann-La Roche
INDUSTRY